Osafune, Kenji http://orcid.org/0000-0001-7238-2763
Funding for this research was provided by:
Japan Agency for Medical Research and Development (Core Center for iPS Cell Research, Technological Development and The Acceleration Program for Intractable Diseases Research utilizing Disease-specific iPS cells, Research Center Network for Realization of Regenerative Medicine)
Article History
Received: 7 August 2020
Accepted: 1 February 2021
First Online: 3 March 2021
Compliance with ethical standards
:
: KO is a founder and member without salary of the scientific advisory boards of iPS Portal, Inc., and a founder and chief scientific advisor of RegeNephro Co., Ltd.
: All experiments with iPSCs were approved by the institutional ethics committees and conducted according to the guidelines of the institutions and the Declaration of Helsinki. All animal experiments were approved by the institutional animal experiment committees and conducted in accordance with the institutional guidelines.
: Informed consent was obtained from all individuals whose iPSCs were used in the studies.